STUDY THE EFFECT OF BLOOD PRESSURE ON THE LEVEL OF HOMOCYSTEINE IN PATIENTS ADMITTED TO THE TIKRIT TEACHING HOSPITAL
Article Sidebar
Main Article Content
Abstract
This study sought to the statement of the relationship between blood pressure and ,its impact on the level of homocysteine in the patient's blood plasma, which is a sulfur amino acid is non-essential produced compound medial during the normal process of metabolism amino acid methionine . It took patients samples of blood pressure of patients admitted in the Tikrit Teaching Hospital of (20) satisfactory sample and (10) a sample control and measured its level of homocysteine in the blood plasma, where he showed statistical analysis of the samples by comparing the samples sick with control samples very high rise significantly (P<0.001) the level of homocysteine in patients compared with healthy
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Montgomery B.: Does paracetamol cause
hypertension . B.Mj; 336:1190-1191. (2008).
2-The sixth report of the joint National committee on
Detectior ,Evaluation, and Diagnosis of High blood
pressure (JNCVI). Arch Intern Med; 157:24-13
(1997).
3- Oliveria S., Lapuerta P., etal. physician related
barriers to the effective management of uncontrolled
hypertension Arch 8 Intern Med ;162:413.(2002).
4- De Gasparo M., Gatl K., Ehight J. and Unger T.
International Union of pharmacology. XXIII. The
angiotensi II receptors. Pharmacol. Rev;52:415-472.
(2000).
5- Chobanian A., Bakris G., Black H., Cushman
W., Green L. and IZZO J., et al;. The Seventh report
of the joint National committee on prevention,
detection, evalution and treatment of high blood
pressure. JAMA; 289:2560-2571.(2003) .
6- Ward R. Familial aggregation and genetic
epidemiology of blood pressure. In: J.H. Laragh, B.M
Brenner (eds), Hypertension: pathophysiology.
Diagnosis and management, pages 81-100.Raven
press,New York,1990.
7- WHO E., Chronic.: Non-communi cable diseases
risk factors survey in Iraq. Ministry of Health and
Ministry of planning and development cooperation,
in collabo ration with WHO;1-58,(2006) .
8- Dioxn M. and Webb E.C. "Tooles of
Biochemistry". Edited by Copero, T.G., Jon wiley
and sons. pub, Academic Press. INC, Newyork.
(1961).
9- Tucker KL, Selhub J, Wilson PW& Rosenberg
IH.; Dietary inake pattern reiates to plasma folate
and homocysteine concentration in the Framingham
Heart Study .J. Nutr 126:3025-31(1996).
10- George N. Welcl, Joseph Loscaizo. New England
J. Medicine 338 ;15:1042-50 (1998).
11- McCully KS. Vascular pathology of
homocysteinemia: Implications for the pathogenesis
of arteriosclerosis. Am J Pathol 1969; 56:111-28.
12- Kruger WD. ; J.Vitamins &Hormones 60:333-
52(2000).
13- Harpreet S. Sood, Matthew J. Hunt & Suresh C.
Tyagl; "Peroxisome prolifrator ameliorates
endothelial dysfunction in amuring model of
hyperhomocysteinemia" American J. Physiology;
284:333-41 (2003) .
14- Ueland P.M, Refsum H., Stabler SP,Malinow
M.R, Andersson A. & Allen R.H, J Clin. Chem.
22;39:1764-79(1993) .
15- S. N. Doshi, J. Goodfellow, M. J. Lewis et al.,
“Homocysteine and endothelial function,”
Cardiovascular research, vol. 42, no. 3, pp. 578-582,
1999
10- Vilaseca et al.Clin.Chem. 43:690-692(1997).
15- Faure-Delanef et al.Am.J.Hum.Genet.60:999-
1001(1997).
11- Donner M, Klein G, Mathes P, Schwandt P,
Richter W: Plasma total homocysteine levels in
patients with early-onset coronary heart disease and a
low cardiovascular risk profile. Metabolism 47:273–
279, (1998).
10- Christen W, Ajani U, Glynn R, Hennekens C:
Blood levels of homocysteine and increased risk of
cardiovascular disease. Arch Intern Med 160:422–
434, (2000).
02- Meleady R, Graham I: Plasma homocysteine as a
cardiovascular risk factor: causal, consequential, or of
no consequence (Review)? Nutr Rev 57:299–305,
(1999).